Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-24 @ 6:48 PM
NCT ID:
NCT02785757
Eligibility Criteria:
Inclusion Criteria:
* Adult patients of both sexes with locally advanced or metastatic adenocarcinoma of any origin, who are scheduled for systemic chemotherapy
* Subjects having signed Informed Consent prior to initiation of any study procedure
* Covered by a Health System
Exclusion Criteria:
* Known bleeding or thrombophilia disorders
* Eastern Cooperative Oncology Group (ECOG) performance status ≥ 3
* Patient immobilized
* Confirmed venous thromboembolism in the last 12 months
* Active bleeding or bleedings in the last 4 weeks requiring hospitalization, transfusion, or surgical intervention
* Anticoagulant therapy at the moment of first sampling (at least one day off for Heparines and DOAc; at least 5 days off for VKA is needed)
* Antiplatelet therapy at the moment of first sampling (only if PRP TGA can be performed at site)
* Severe hepatic insufficiency
* Life expectancy of less than 3 months
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02785757
Study Brief:
Protocol Section:
NCT02785757